Company:  KBL MERGER CORP. IV (KBLM)
Form Type:  S-4/A
Filing Date:  2/10/2020 
CIK:  0001690080 
Address:  150 WEST 56TH STREET SUITE 5901 
City, State, Zip:  NEW YORK, New York 10019 
Telephone:  212-319-5555 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$10.98  
Change: 
0.00 (0.00%)  
Trade Time: 
Aug 05  
Market Cap: 
$48.58M
Trade KBLM now with 

© 2020  
Description of Business
We are a blank check company organized under the laws of the State of Delaware on September 7, 2016. We were formed for the purpose of effecting a merger, capital stock exchange, stock purchase, asset acquisition or other similar business combination with one or more operating businesses, which we refer throughout this report as our initial business combination. We have focused our efforts on acquiring an operating company in the healthcare and related wellness industry although our efforts in identifying a prospective target business will not be limited to a particular industry. Business Combination On July 25, 2019, we, KBL Merger Sub, the 180 Parties and the Stockholder Representative entered into the Business Combination Agreement pursuant to which KBL Merger Sub will merge with and into 180 with 180 surviving the merger and continuing as our wholly-owned subsidiary.
Register and access this filing in:     
  FORM S-4/A
    SUBJECT TO COMPLETION, DATED FEBRUARY 7, 2020
    TABLE OF CONTENTS
    SUMMARY TERM SHEET
    Risk Factors
    SELECTED HISTORICAL FINANCIAL INFORMATION OF KBL
    SELECTED HISTORICAL CONSOLIDATED FINANCIAL DATA OF CBR PHARMA
    SELECTED UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL DATA
    CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
    RISK FACTORS
    Nasdaq Stock Market Listing
      Indemnification
    Material United States Federal Income Tax Considerations
      Foreign Property Information Reporting
    Description of Special Voting Shares
    MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
      Liquidity and Capital Resources
    BUSINESS OF KBL
      Employees
      NAME AND TITLE
      Compensation Committee Interlocks and Insider Participation
    EXECUTIVE COMPENSATION
      COMPENSATION TABLE
    Director Compensation
      Competition
      Legal Proceedings
    Management
      NAME AND TITLE
      NAME AND TITLE
      BENEFICIAL OWNERS
    CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS
    DESCRIPTION OF SECURITIES
    Our Transfer Agent, Rights Agent and Warrant Agent
    Securities Eligible for Future Sale
    LEGAL MATTERS
    EXPERTS
    WHERE YOU CAN FIND ADDITIONAL INFORMATION
    INDEX TO THE FINANCIAL STATEMENTS
      Report of Independent Registered Public Accounting Firm
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        CASH FLOW
      NOTES TO FINANCIAL STATEMENTS
    Underwriting Agreement
      STOCKHOLDERS EQUITY
      STOCKHOLDERS EQUITY
      REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        CASH FLOW
        STOCKHOLDERS EQUITY
        STOCKHOLDERS EQUITY
    NOTE 4 - REORGANIZATION AND RECAPITALIZATION
      REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        CASH FLOW
        STOCKHOLDERS EQUITY
      REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        CASH FLOW
        STOCKHOLDERS EQUITY
      INDEMNIFICATION
    Section 9.9 Counterparts; Electronic Signatures. This ...
    PART II
      Item 20. Indemnification of Directors and Officers.
      Item 21. Exhibits and Financial Statement Schedules.
    EXHIBIT INDEX
      Item 22. Undertakings.
    POWER OF ATTORNEY
  EXHIBIT 8.2
  EXHIBIT 23.1
    CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
  EXHIBIT 23.2
    Independent Registered Public Accounting Firm's Consent
    Independent Registered Public Accounting Firm's Consent
    Independent Registered Public Accounting Firm's Consent
  EXHIBIT 99.1